APOB and fatty liver disease: Our results confirm that male APOB-100 transgenic animals show more severe metabolic disturbances after 7 months of an HFD compared to females, with regard to, for example, fasting glucose, serum triglyceride (TG), tumor necrosis factor α (TNFα) levels, and hepatic steatosis.